Cart
sales@molnova.com
Etripamil
CAS No. 1593673-23-4
Etripamil( MSP-2017 | (-)-MSP-2017 )
Catalog No. M23694 CAS No. 1593673-23-4
Etripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 68 | In Stock |
|
| 5MG | 112 | In Stock |
|
| 10MG | 173 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 693 | In Stock |
|
| 200MG | 1088 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEtripamil
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel.
-
DescriptionEtripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel. It has a rapid onset of action designed for intranasal administration. It is also used to treat Paroxysmal Supraventricular Tachycardia.
-
In Vitro——
-
In Vivo——
-
SynonymsMSP-2017 | (-)-MSP-2017
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorL-type calcium channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1593673-23-4
-
Formula Weight452.59
-
Molecular FormulaC27H36N2O4
-
Purity>98% (HPLC)
-
SolubilityEthanol : 110 mg/mL (243.05 mM; Need ultrasonic)
-
SMILESO=C(OC)C1=CC=CC(CCN(CCC[C@](C2=CC=C(OC)C(OC)=C2)(C#N)C(C)C)C)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stambler BS, et al. Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. J Am Coll Cardiol. 2018 Jul 31;72(5):489-497.
molnova catalog
related products
-
CALP3
Cell-permeable calmodulin (CaM) agonist that binds to the EF-hand/Ca2+-binding site. Activates phosphodiesterase in the absence of Ca2+ and inhibits Ca2+-mediated cytotoxicity and apoptosis (IC50 = 33 μM).
-
ACT 709478
ACT 709478 is a potent, selective, orally-bioavailable, brain penetrant T-type calcium channel blocker with IC50 of 6.4, 18, and 7.5 nM for Cav3.1, Cav3.2, and Cav3.3 channels respectively.
-
Calcium Channel anta...
Calcium Channel antagonist 3 is a voltage-gated calcium channel inhibitor (IC50 : 5-20 μM).
